Soligenix Inc (SNGX) Institutional Ownership & 13F Filings (Q2 2026)

SNGX ranks #8651 out of 37507 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

SNGX is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

18 institutions disclose a position in SNGX, but none treat it as a major bet — even Citadel Advisors LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Morgan Stanley has trimmed its SNGX position for two straight quarters, cutting it by $3.4K while still holding $1.4K.

SNGX reported a net loss of $10.2M over the trailing twelve months.

• Not yet profitable — net loss of $10.2M over the trailing twelve months
• Revenue declined 85.8% year over year
• Net income improved year over year, from -$10.4M to -$10.2M
• Operating cash flow was negative, using $10.3M in cash
• Current ratio of 2.39x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.75x equity — within a conventional range